Clinical Trials
3 trialsNCT01204099 2018-05-16
Study of PX-866 and Docetaxel in Solid Tumors
Seagen Inc.
Phase 1/2 Completed
NCT01252628 2018-05-16
Phase 1 and 2 Study of PX-866 and Cetuximab
Seagen Inc.
Phase 1/2 Completed
NCT01616199 2018-05-16
Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma
Seagen Inc.
Phase 1/2 Terminated